Epiminder Ltd (EPI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Epiminder Ltd (EPI) has a cash flow conversion efficiency ratio of -0.342x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-34.30 Million ≈ $-24.27 Million USD) by net assets (AU$100.27 Million ≈ $70.95 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Epiminder Ltd stock valuation for the company's overall valuation and market capitalisation.
Epiminder Ltd - Cash Flow Conversion Efficiency Trend (2023–2025)
This chart illustrates how Epiminder Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View EPI share price today for real-time trading data and today's change.
Epiminder Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Epiminder Ltd ranked by their cash flow conversion efficiency. Review how financially flexible is Epiminder Ltd to assess the company's free cash flow relative to its total liabilities.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Surgical Innovations Group plc
LSE:SUN
|
0.106x |
|
MyHotelMatch S.A.
PA:MHM
|
0.019x |
|
Trump Media & Technology Group Corp.
NASDAQ:DJTWW
|
0.007x |
|
Thalassa Holdings Ltd
LSE:THAL
|
-0.026x |
|
Woodbois Ltd
LSE:WBI
|
-0.016x |
|
China Steel Corp Pref
TW:2002A
|
0.020x |
|
TC Unterhaltungselektronik AG
F:TCU
|
N/A |
|
Westmount Energy Limited
LSE:WTE
|
0.000x |
Annual Cash Flow Conversion Efficiency for Epiminder Ltd (2023–2025)
The table below shows the annual cash flow conversion efficiency of Epiminder Ltd from 2023 to 2025. Also see EPI total assets for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$107.39 Million ≈ $75.98 Million |
AU$-16.98 Million ≈ $-12.01 Million |
-0.158x | -108.95% |
| 2024-06-30 | AU$-7.79 Million ≈ $-5.51 Million |
AU$-13.77 Million ≈ $-9.74 Million |
1.767x | +117.26% |
| 2023-06-30 | AU$1.39 Million ≈ $984.74K |
AU$-14.25 Million ≈ $-10.08 Million |
-10.239x | -- |
About Epiminder Ltd
Epiminder Limited develops and manufactures a monitoring device to improve treatment of patients suffering with epileptic seizures and related conditions. It offers Minder system, an implantable sub scalp electroencephalography (EEG) monitoring system which is designed for continuous monitoring of brain activity. The company's Minder system comprises Minder implant, a sub scalp electrode with mul… Read more